A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

NPS Pharmaceuticals

About NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development, and commercialization of therapeutic small molecules and recombinant proteins. Current products and product candidates include treatments for bone and mineral disorders (osteoporosis & hyperparathyroidism), gastrointestinal disorders (GI) and central nervous system disorders (CNS).

The most advanced drug candidates being developed by NPS include PREOS® (recombinant human parathyroid hormone) for the treatment of osteoporosis, and teduglutide for treating gastrointestinal disorders including Short Bowel Syndrome, a condition in which much of the intestinal tract has been surgically removed due to injury or disease resulting in inefficient absorption of nutrients and fluids. Teduglutide has been granted orphan drug status by both the Food and Drug Administration and the Commission of the European Communities for this condition.



Pipeline for NPS Pharmaceuticals



PREOS® (recombinant human parathyroid hormone), Preotact, Calcilytics -- for the treatment of osteoporosis

Teduglutide for treating gastrointestinal disorders including Short Bowel Syndrome

GlyT-1 - Schizophrenia



More Info on NPS Pharmaceuticals


Home Page

Key Statistics for NPS

Basic Chart for NPS

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.